Median age | 61 (range: 46–70) |
Sex | |
Female | 5 |
Male | 4 |
Race | |
White | 7 |
African–American | 2 |
Smoking status | |
Current | 1 |
Former | 7 |
Never | 1 |
Performance status | |
0 | 3 |
1 | 6 |
Histology | |
ES-SCLC* | 6 |
Atypical carcinoid | 2 |
High-grade neuroendocrine carcinoma | 1 |
Brain metastases at baseline† | 2 |
** 1 refractory ES-SCLC, 4 relapsed ES-SCLC with 1 patient with stable disease after 2 cycles of second-line chemotherapy, 1 with stable disease after first-line chemotherapy
†All treated before study entry
ES-SCLC, extensive-stage small-cell lung cancer.